PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Horizon Pharma: Talent Management from the Ground Up

Re-inventing Pharma's Talent Search

Hiring a Chief Diversity Officer

Advertisement
Europe
Health Technology's Double-Edged Sword
Europe has been slow to act on emerging technologies, but the complex issues clouding EHRs and gene editing offer pause. Reflector reports
/Read more/
Advertisement
Patient Adherence: A Hard Pill to Swallow?
North America: Thursday, April 11, 2019 at 1pm EDT | 12pm CDT | 10am PDT
Asia-Pacific: Thursday, April 11, 2019 at 11:30am IST | 2pm CST | 3pm JST
Register Now
US
Biosimilars Name Game Remains Thorny Issue
Follow-on product naming and messaging challenge FDA and the industry. Jill Wechsler reports
/Read more/
Advertisement
Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
On Demand
Learn More
Outlook
M&A: Range of Fundamental Factors Will Drive Strong Deal Flow
The outlook for pharma M&A continues to be strong, writes Michael Jewell.
/Read more/
Advertisement
Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
On Demand
Learn More
Talent
Re-inventing Pharma's Talent Search
Thinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm
/Read more/
Talent
Hiring a Chief Diversity Officer
Nine ways pharma companies can maximize a CDO's potential value and impact on driving innovation as a business mandate
/Read more/
The Pharm Exec Podcast: Digital Medicine
The Pharm Exec editors speak with Bill Carson, President & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. and Kabir Nath, President & CEO of Otsuka North America Pharmaceuticals about digital medicine, mental health therapies, and creating a smooth and collaborative relationship between R&D and commercial
/Click here to listen/
Calendar
/ April 16–17: eyeforpharma Philadelphia /
Philadelphia, PA
/ May 15: MDR Workshop: Transitioning to the EU MDR and Managing Legacy Devices /
Brussels, Belgium
/ May 20–22: 21st Medicaid and Government Pricing Congress /
Orlando, FL
/ June 3–6: BIO International Convention /
Philadelphia, PA
/ June 12–13: Rare Disease Innovation and Partnering Summit /
Philadelphia, PA
/ June 14–15:13th World Drug Delivery Summit /
Montreal, Canada

Industry update
// Sanofi (Paris, France) appointed Ameet Nathwani, M.D. as Chief Digital Officer in addition to his current role of Executive Vice President, Chief Medical Officer. // Enterome (Paris, France and Cambridge, MA) appointed Jan Fagerberg M.D., Ph.D. as Chief Medical Officer and Catherine Mathis, Pharm.D. as Chief Development Officer. // Innate Pharma (Marseille, France) named Jennifer Butler as Executive Vice President and General Manager of Innate Pharma US Inc. // Dirk de Naeyer, formerly Head of Supply Chain at Kiadis Pharma (Amsterdam, The Netherlands) took up the position as the company's Chief Operations Officer, as a planned succession from Jan Feijen. Kiadis also appointed Martine Nolan as Head of Quality Assurance. // Dr. Athanasios Papadopoulos joined Emergex (Oxford, UK) as Chief Medical Officer. // ReViral (London, UK) appointed Seth Hetherington as Chief Medical Officer. // Hikma Pharmaceuticals (London, UK) announced the appointment of Cynthia Schwalm as an independent non-executive director, effective June 1, 2019. // Achilles Therapeutics (Stevenage, UK) named Dr Markus Dangl as Chief Scientific Officer. // Mundipharma (Cambridge, UK) appointed Patrice Grand as European Director of Corporate Communications. // InSphero (Schlieren, Switzerland) named Prof. Armin Wolf as Chief Scientific Officer.
update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com